Is Beaten-Down Phibro Animal Health Stock a Buy Following an Insider Purchase of 10,000 Shares?
This animal health provider, serving global livestock markets, reported a notable insider buy in its latest SEC filing.
Is Beaten-Down Phibro Animal Health Stock a Buy Following an Insider Purchase of 10,000 Shares?
Overview
E. Thomas Corcoran, Director of Phibro Animal Health Corporation (NASDAQ:PAHC), reported the acquisition of 10,000 shares of Common Stock at a weighted average price of $31.77 per share on May 29, 2026, according to a SEC Form 4 filing.
Transaction value based on SEC Form 4 weighted average purchase price ($31.77); post-transaction value based on May 29, 2026 transaction price ($31.77).
Details
* 1-year price change calculated using June 12, 2026, as the reference date.
Source
Originally published at www.fool.com.
Related Articles
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Data may be delayed up to 15 minutes. Past performance is not indicative of future results. Consult a licensed financial advisor before making investment decisions.
